Q. Consider the following statements:
1.India has set a target to eliminate tuberculosis (TB) earlier than the global target set by the United Nations.
2.BPaLM regimen is primarily designed to treat extrapulmonary TB.
Which of the statement(s) given above is/are correct?
Answer: A
Notes:
Explanation –
Statement 1 is correct. India has set a target to eliminate TB by 2025, which is five years ahead of the global target of 2030 set by the United Nations Sustainable Development Goals.
Statement 2 is incorrect. The BPaLM regimen is primarily designed for the treatment of multidrug-resistant TB (MDR-TB). It has been recently approved for use in several countries, including India. It is a novel treatment option that includes a combination of drugs: Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin. This regimen is intended to be a more effective, safer, and quicker alternative to traditional MDR-TB treatments, reducing the treatment duration from up to 20 months to just six months.
Source: The Hindu
